Legence Corp. LGN
52.52
0.07
0.13%
as of 25 Sep
- Market cap
- $5.7B
- P/E
- 0.0×
Follow LGN
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 1.00 |
P/FCF ratio |
0.00 | 0.00 | 11.65 |
P/Operating CF |
0.00 | 0.00 | 26.97 |
P/B ratio |
0.00 | 0.00 | 3.24 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 1.24 |
EV/EBITDA |
0.00 | 0.00 | 15.44 |
EV/Operating CF |
16.64 | 16.64 | 12.28 |
EV/FCF |
25.86 | 25.86 | 14.38 |
Quick Ratio |
— | 1.29 | 1.15 |
Current Ratio |
— | 1.84 | 1.57 |
Net Debt/EBITDA |
0.00 | 7.49 | 2.93 |
Debt/Assets |
0.00% | 68.39% | 30.94% |
Debt/Equity |
0.00 | 7.90 | 1.05 |
Asset Turnover |
0.00 | 1.78 | 1.01 |
Operating CF/Net income |
(0.74) | (1.02) | (4.30) |
Capex/Depreciation |
(0.16) | (0.14) | (0.26) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | 0.00% | (12.05%) | |
| 0.00% | (2.43%) | (2.38%) | |
ROIC |
0.00% | 2.54% | 2.77% |
Return on Tangible Assets |
0.00% | (6.82%) | (12.09%) |
Average Days of Receivables |
0.00 | 78.02 | 83.58 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
11.52% | 11.57% | 13.43% |
Intangible Assets out of Total Assets |
0.00 | 0.60 | 0.49 |
Share Based Compensation of Revenue |
0.62% | 0.26% | 2.65% |
Graham Net Nets |
0.00 | 0.00 | (0.31) |
Graham Number |
0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.79%) | (0.79%) | (0.79%) |
Free Cash Flow Yield |
0.00% | 0.00% | 8.58% |
Revenue per Share |
0.00 | 0.00 | 42.95 |
Operating CF per Share |
0.00 | 0.00 | 4.33 |
Capex per Share |
0.00 | 0.00 | (0.63) |
Free Cash Flow per Share |
0.00 | 0.00 | 3.69 |
Cash per Share |
— | 0.00 | 3.88 |
Shareholders Equity per Share |
0.00 | 0.00 | 13.28 |
Interest Debt per Share |
— | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 13.28 |
Free Cash Flow |
17.20 | 10.53 | 219.32 |
Working Capital |
— | 345.31 | 402.19 |
Capital Expenditures |
(16.72) | (18.74) | (37.55) |
Net Current Asset Value |
0.00 | (1,392.49) | (780.25) |
EV/EBIT |
0.00 | 0.00 | 51.23 |
Capex to Sales |
0.01 | 0.01 | 0.01 |
Net Profit Margin |
(2.85%) | (1.36%) | (2.34%) |
Price to Operating Income |
0.00 | 0.00 | 41.50 |
| Other line items | |||
Depreciation/Fixed assets |
0.00 | 1.82 | 1.55 |
Cash ROIC |
0.00% | (2.33%) | 8.90% |
Accounts Receivable Turnover |
0.00 | 0.00 | 4.94 |
Accounts Payable Turnover |
0.00 | 0.00 | 10.81 |
Inventory Turnover |
0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 27.68 | 44.60 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 516.34 |
Average Payables |
— | — | 186.33 |
Average Assets |
— | 1,176.25 | 2,515.95 |
Average Common Equity |
— | — | 496.19 |
Columns are period end dates